Delivery Order SPE2DB20D9331-SPE2DB25FL1C9

Award Date 4/21/25
Potential Completion Date 5/12/25
Potential Value $31K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $14,208 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Mirena 52 mg intrauterine systems, a prescription contraceptive product. The contract has an ultimate completion date of December 18, 2024. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a $1,562.31 firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract was awarded by the Defense Logistics Agency (DLA) to provide Mirena 52 mg systems, a type of intrauterine contraceptive device, with a period of performance through July 17, 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $5,207.70 contract is for the delivery of Mirena 52 mg systems, a type of intrauterine contraceptive device. The contract has an ultimate completion date of February 20, 2025 and is not associated with any set-aside designations. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 Indefinite Delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,736 contract is for the delivery of Mirena 52 mg systems, a type of intrauterine contraceptive device. The contract has an ultimate completion date of November 29, 2024 and is not associated with any set-aside designations. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of Mirena 52 mg systems, a type of intrauterine contraceptive device, with a ceiling value of $26,038.50 and a period of performance ending on May 27, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
This firm-fixed-price delivery order was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,960 contract is for the supply of Mirena 52 mg systems, a type of intrauterine contraceptive device. It was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of June 6, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC)...
This is a $3,552.00 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Mirena 52 mg systems, a type of contraceptive device, with a period of performance through May 7, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA, valued up to $499,999,999, that allows the agency...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth up to $13,024.00 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of Mirena 52 mg intrauterine systems, a contraceptive product. This delivery order is issued under DMS Pharmaceutical Group's existing indefinite delivery contract (IDV) SPE2DB with DLA, valued at up to $4,999,999 through 2025, which...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $2,960.00 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of Mirena 52 mg Systems, a type of intrauterine contraceptive device. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which covers a comprehensive range...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract worth up to $1,184.00 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 4,564,029,380 units of Mirena 52 mg contraceptive intrauterine systems. The delivery order has an ultimate completion date of April 8, 2024 and was awarded on March 18, 2024. This contract is part of DMS Pharmaceutical Group's existing indefinite delivery...
  • SPE2DB20D9331
    Indefinite Delivery Contract
  • SPE2DB20D9331-SPE2DB25FL1C9
    Delivery Order

This is a $31,246.20 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract is for the delivery of Mirena 52 mg systems, a type of intrauterine contraceptive device, with a period of performance through May 12, 2025.

DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. This positions DMS as a key supplier in the federal pharmaceutical supply chain, providing direct distribution of prescription drugs and pharmacy services to Department of Defense healthcare sites. The contract award was not set aside for any socioeconomic category.

Generated 7/21/25, 7:47 PM